Literature DB >> 21069342

Signal intensity in T2' magnetic resonance imaging is related to brain glioma grade.

Laura Saitta1, Oliver Heese, Ann-Freya Förster, Jakob Matschke, Susanne Siemonsen, Lucio Castellan, Manfred Westphal, Jens Fiehler, Einar Goebell.   

Abstract

OBJECTIVES: T2' values reflect the presence of deoxyhaemoglobin related to high local oxygen extraction. We assessed the feasibility of T2' imaging to display regions with high metabolic activity in brain gliomas.
METHODS: MRI was performed in 25 patients (12 female; median age 46 years; range 2-69) with brain gliomas with additional T2 and T2* sequences. T2' maps were derived from T2 and T2*. Dynamic susceptibility weighted contrast (DSC) perfusion was performed in 12/25 patients. Images were visually assessed by two readers and five ROIs were evaluated for each patient. Pearson correlation, Mann-Whitney and Kruskal-Wallis tests were applied for statistical analysis.
RESULTS: Three patients were not further evaluated because of artefacts. Mean values of high-grade (III-IV) gliomas showed significantly lower T2' values than low-grade (II) gliomas (p < 0.001). An inverse relationship was observed between rCBV and sqr (T2') (r = -0.463, p < 0.001). No correlation was observed between T2' and rCBV for grade II tumours (r = 0.038; p = 0.875).
CONCLUSIONS: High-grade tumours revealed lower T2' values, presumably because of higher oxygen consumption in proliferating tissue. Our results indicate that T2' imaging can be used as an alternative to DSC perfusion in the detection of subtle deviations in tumour metabolism.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21069342     DOI: 10.1007/s00330-010-2004-3

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  40 in total

Review 1.  Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging.

Authors:  Soonmee Cha; Edmond A Knopp; Glyn Johnson; Stephan G Wetzel; Andrew W Litt; David Zagzag
Journal:  Radiology       Date:  2002-04       Impact factor: 11.105

2.  Observer reliability in histological grading of astrocytoma stereotactic biopsies.

Authors:  M A Mittler; B C Walters; E G Stopa
Journal:  J Neurosurg       Date:  1996-12       Impact factor: 5.115

Review 3.  From the archives of the AFIP: Oligodendroglioma and its variants: radiologic-pathologic correlation.

Authors:  Kelly K Koeller; Elisabeth J Rushing
Journal:  Radiographics       Date:  2005 Nov-Dec       Impact factor: 5.333

4.  Interobserver reproducibility among neuropathologists and surgical pathologists in fibrillary astrocytoma grading.

Authors:  R A Prayson; D P Agamanolis; M L Cohen; M L Estes; B K Kleinschmidt-DeMasters; F Abdul-Karim; S P McClure; B A Sebek; R Vinay
Journal:  J Neurol Sci       Date:  2000-04-01       Impact factor: 3.181

5.  Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging.

Authors:  Bahattin Hakyemez; Cuneyt Erdogan; Naile Bolca; Nalan Yildirim; Gokhan Gokalp; Mufit Parlak
Journal:  J Magn Reson Imaging       Date:  2006-10       Impact factor: 4.813

6.  Blood-oxygen-level-dependent MRI allows metabolic description of tissue at risk in acute stroke patients.

Authors:  Benjamin S Geisler; Frank Brandhoff; Jens Fiehler; Christian Saager; Oliver Speck; Joachim Röther; Hermann Zeumer; Thomas Kucinski
Journal:  Stroke       Date:  2006-06-01       Impact factor: 7.914

7.  Analysis of 11C-methionine uptake in low-grade gliomas and correlation with proliferative activity.

Authors:  T Kato; J Shinoda; N Oka; K Miwa; N Nakayama; H Yano; T Maruyama; Y Muragaki; T Iwama
Journal:  AJNR Am J Neuroradiol       Date:  2008-08-07       Impact factor: 3.825

8.  Imaging response criteria for recurrent gliomas treated with bevacizumab: role of diffusion weighted imaging as an imaging biomarker.

Authors:  Rajan Jain; Lisa M Scarpace; Shehanaz Ellika; Roy Torcuator; Lonni R Schultz; David Hearshen; Tom Mikkelsen
Journal:  J Neurooncol       Date:  2009-10-27       Impact factor: 4.130

Review 9.  In vivo magnetic resonance spectroscopy of human brain tumors.

Authors:  P B Barker; J D Glickson; R N Bryan
Journal:  Top Magn Reson Imaging       Date:  1993

10.  Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results.

Authors:  Ji Hoon Shin; Ho Kyu Lee; Byung Duk Kwun; Jin-Suh Kim; Weechang Kang; Choong Gon Choi; Dae Chul Suh
Journal:  AJR Am J Roentgenol       Date:  2002-09       Impact factor: 3.959

View more
  10 in total

1.  Is T2* enough to assess oxygenation? Quantitative blood oxygen level-dependent analysis in brain tumor.

Authors:  Thomas Christen; Benjamin Lemasson; Nicolas Pannetier; Regine Farion; Chantal Remy; Greg Zaharchuk; Emmanuel L Barbier
Journal:  Radiology       Date:  2011-12-09       Impact factor: 11.105

2.  Quantitative T2 mapping of recurrent glioblastoma under bevacizumab improves monitoring for non-enhancing tumor progression and predicts overall survival.

Authors:  Elke Hattingen; Alina Jurcoane; Keivan Daneshvar; Ulrich Pilatus; Michel Mittelbronn; Joachim P Steinbach; Oliver Bähr
Journal:  Neuro Oncol       Date:  2013-08-07       Impact factor: 12.300

3.  Bevacizumab impairs oxidative energy metabolism and shows antitumoral effects in recurrent glioblastomas: a 31P/1H MRSI and quantitative magnetic resonance imaging study.

Authors:  Elke Hattingen; Alina Jurcoane; Oliver Bähr; Johannes Rieger; Jörg Magerkurth; Sandra Anti; Joachim P Steinbach; Ulrich Pilatus
Journal:  Neuro Oncol       Date:  2011-09-02       Impact factor: 12.300

Review 4.  Cerebral oxygen extraction fraction MRI: Techniques and applications.

Authors:  Dengrong Jiang; Hanzhang Lu
Journal:  Magn Reson Med       Date:  2022-05-05       Impact factor: 3.737

5.  Low-grade (WHO II) and anaplastic (WHO III) gliomas: differences in morphology and MRI signal intensities.

Authors:  Max-Ludwig Schäfer; Martin H Maurer; Michael Synowitz; Joost Wüstefeld; Tim Marnitz; Florian Streitparth; Edzard Wiener
Journal:  Eur Radiol       Date:  2013-05-19       Impact factor: 5.315

6.  Mapping of cerebral metabolic rate of oxygen using dynamic susceptibility contrast and blood oxygen level dependent MR imaging in acute ischemic stroke.

Authors:  Alexandra S Gersing; Monika Ankenbrank; Benedikt J Schwaiger; Vivien Toth; Insa Janssen; Hendrik Kooijman; Silke Wunderlich; Jan S Bauer; Claus Zimmer; Christine Preibisch
Journal:  Neuroradiology       Date:  2015-09-12       Impact factor: 2.804

7.  MR-based hypoxia measures in human glioma.

Authors:  Vivien Tóth; Annette Förschler; Nuria M Hirsch; Jürgen den Hollander; Hendrik Kooijman; Jens Gempt; Florian Ringel; Jürgen Schlegel; Claus Zimmer; Christine Preibisch
Journal:  J Neurooncol       Date:  2013-08-07       Impact factor: 4.130

8.  Quantitative T1 and T2 mapping in recurrent glioblastomas under bevacizumab: earlier detection of tumor progression compared to conventional MRI.

Authors:  Stephanie Lescher; Alina Jurcoane; Andreas Veit; Oliver Bähr; Ralf Deichmann; Elke Hattingen
Journal:  Neuroradiology       Date:  2014-10-07       Impact factor: 2.804

9.  Using R2* values to evaluate brain tumours on magnetic resonance imaging: preliminary results.

Authors:  Zhenghua Liu; Haibo Liao; Jianhua Yin; Yanfang Li
Journal:  Eur Radiol       Date:  2013-11-26       Impact factor: 5.315

10.  Quantitative MRI for analysis of peritumoral edema in malignant gliomas.

Authors:  Ida Blystad; J B Marcel Warntjes; Örjan Smedby; Peter Lundberg; Elna-Marie Larsson; Anders Tisell
Journal:  PLoS One       Date:  2017-05-23       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.